CDSCO License for Liposuction catheter
Medical Device Information
Intended Use
A rigid tube inserted into the subcutaneous layer transdermally for removal of fatty deposits. Aspiration is performed with an appropriate unit. This device is for single-use.

Comprehensive Guide to CDSCO Licensing for Liposuction Catheters (Class B Medical Devices)
Introduction: Understanding Liposuction Catheters and Regulatory Importance
Liposuction catheters are specialized medical devices designed as rigid tubes inserted transdermally into the subcutaneous layer for the removal of fatty deposits. These single-use devices are critical in dermatological and plastic surgery procedures, particularly for body contouring. Given their invasive nature and patient safety implications, obtaining the appropriate regulatory approvals is essential before marketing or manufacturing liposuction catheters in India.
At our consultancy, with over 25 years of experience and having supported 500+ companies, we understand the nuances involved in securing CDSCO licenses. The regulatory framework ensures that manufacturers comply with safety, quality, and efficacy standards, protecting end-users while facilitating market access.
CDSCO Regulatory Framework for Liposuction Catheters
Liposuction catheters fall under the dermatological and plastic surgery category, governed by the Central Drugs Standard Control Organization (CDSCO) in India. CDSCO mandates compliance with the Medical Devices Rules, 2017 and subsequent notifications, including Notification 29/Misc./03/2020-DC (147) dated 26.7.2021, which specifically addresses these device types.
Under CDSCO regulations, liposuction catheters are classified as Class B devices due to their moderate risk profile. This classification influences the licensing procedure, documentation, and authority from whom the license must be obtained.
Risk Classification and License Requirements for Class B Devices
Class B devices like liposuction catheters are considered low to moderate risk, requiring a manufacturing license under the MD5 category (Application Form MD3). The licensing authority is the State Licensing Authority, unlike higher-risk devices which require central approval.
The MD5 license process includes obtaining a test license (Form MD13), product testing from government-approved laboratories, audit by notified bodies, and submission of technical documentation.
Manufacturing License Process (MD5) for Liposuction Catheters
The journey to acquiring an MD5 license for liposuction catheters involves multiple well-defined steps:
Application for Test License (MD13): Initiate the process by applying for a test license to manufacture the device on a trial basis. This phase typically spans 1.5 to 2 months.
Product Testing: Conduct mandatory testing at CDSCO-approved laboratories to verify compliance with performance and safety standards. You can find a list of these labs through the CDSCO Testing Laboratories.
Document Preparation: Compile comprehensive documentation including Device Master File, Plant Master File, Risk Management File, and Quality Management System (QMS) documents.
License Application (Form MD3): Submit the manufacturing license application via the CDSCO MD Online Portal for the MD5 license.
Audit by Notified Body: Engage a notified body from the official Notified Bodies List to audit your manufacturing facility and QMS.
Resolution of Queries: Address any observations or queries raised by the licensing authority or notified body promptly.
Grant of License (Form MD5): Upon satisfactory compliance, the license is granted.
Manufacturing License Documents Required for Liposuction Catheters
For a successful MD5 license application, prepare the following documents meticulously:
- Company Constitution (Incorporation Certificate, Memorandum & Articles of Association)
- Proof of Ownership or Lease Agreement of Manufacturing Premises
- Details and Qualifications of Technical Staff
- Fire NOC and Pollution Control Board NOC
- Device Master File (DMF) detailing design, specifications, and manufacturing process (Refer to our comprehensive Device Master File guide)
- Plant Master File (PMF) describing the manufacturing site and infrastructure (Plant Master File Guide)
- Essential Principles Checklist confirming compliance with Indian Medical Device Rules
- Risk Management File documenting hazard analysis and mitigation strategies (Risk Management)
- Test Reports from approved laboratories
- Product Labels and Instructions for Use (IFU)
- Quality Management System (QMS) documents, typically ISO 13485 compliant
Import License Process (MD15) for Liposuction Catheters
For importers, the CDSCO requires an MD15 import license issued by the Central Licensing Authority. The process involves:
- Detailed document preparation including existing manufacturing license, Free Sale Certificate, ISO 13485:2016 certification, CE Certificate, Device and Plant Master Files, and Wholesale License.
- Filing application on the CDSCO MD Online Portal with Form MD14.
- Resolution of queries from CDSCO officials.
Notably, the import license process takes approximately 5-6 months, with fees varying based on the risk class and number of products.
Import License Documents Required
Key documentation includes:
- Valid Manufacturing License from the country of origin
- Free Sale Certificate (FSC) confirming device approval in the exporter's country
- ISO 13485:2016 certification
- CE Certificate (if applicable)
- Device and Plant Master Files
- Wholesale License for distribution in India
- Company Constitution documents
For detailed procedural guidance, refer to our Import License Guide.
Timeline and Processing Duration
Process Stage | Duration |
---|---|
Test License (MD13) | 1.5 to 2 months |
Product Testing | 1 to 1.5 months |
Documentation Preparation | 1 month |
License Application & Audit | 1 to 1.5 months |
Query Resolution | 2 to 3 weeks |
Total Time | Approximately 3 to 4 months |
Government Fees and Costs
For Liposuction Catheters (Class B, MD5 License):
- Application Fee: Rs. 5,000 per application
- Product Fee: Rs. 500 per product
- Additional costs may include testing fees at government-approved labs and fees charged by notified bodies for audits.
Budgeting realistically for these fees is essential to avoid delays.
Common Challenges and Solutions
Challenge: Delays in obtaining test reports from approved labs Solution: Engage with labs early, ensure samples meet submission criteria, and follow up regularly.
Challenge: Incomplete or inadequate documentation Solution: Utilize checklists and expert reviews before submission. Our team can assist in preparing compliant Device and Plant Master Files.
Challenge: Audit observations leading to queries Solution: Maintain robust QMS and document control. Prompt and detailed responses to queries expedite approval.
Expert Consultation and Support
Navigating the CDSCO licensing landscape for liposuction catheters requires specialized expertise. We provide end-to-end support including:
- Gap analysis and readiness assessment
- Preparation of DMF, PMF, Risk Management, and QMS documentation
- Coordination with notified bodies and testing labs
- Application filing and query management
Our track record with 500+ successful client projects ensures your regulatory journey is smooth and compliant.
Getting Started with Your CDSCO License Application
To initiate your licensing process for liposuction catheters:
- Register your company and create a user account on the CDSCO MD Online Portal.
- Conduct a detailed review of your manufacturing setup and technical team qualifications.
- Prepare your Device Master File and Plant Master File with precision.
- Apply for the Test License (Form MD13) to begin initial manufacturing and testing.
- Simultaneously, schedule product testing at CDSCO-approved laboratories.
- Engage with a notified body early to plan your audit.
Taking these practical steps with expert guidance ensures that your liposuction catheter manufacturing license is granted efficiently, enabling you to enter the Indian market with confidence and compliance.
For personalized assistance and tailored compliance strategies, contact our regulatory consulting team today.